Immunic, Inc. (IMUX)
0.5337
+0.02
(+4.61%)
USD |
NASDAQ |
Dec 31, 16:00
0.548
+0.01
(+2.68%)
After-Hours: 06:58
Immunic Total Assets (Quarterly): 40.70M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aardvark Therapeutics, Inc. | 133.23M |
| CEL-SCI Corp. | 28.16M |
| AIM ImmunoTech, Inc. | 5.494M |
| IGC Pharma, Inc. | 9.743M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.20M |
| Shareholders Equity (Quarterly) | 10.50M |
| Debt to Equity Ratio | 0.0754 |
| Current Ratio | 1.306 |
| Net Debt Paydown Yield | 0.04% |